Drug-resistant tuberculosis
Do you want to receive a message when there is new research on Drug-resistant tuberculosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication appears one sentence explaining what was investigated — and you receive a notification as soon as new research on Drug-resistant tuberculosis becomes available. View what Premium costs.
Publications (1322)
- Advanced tuberculosis diagnosis system: Integrating case-based reasoning with nearest neighbor algorithm. (2025/10/01) ♡
- Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India. (2025/10/01) ♡
- Effect of Poverty and Rural Settings on Catastrophic Expenditure in Multi-Drug-Resistant Tuberculosis: An Exploratory Study using Propensity Score Matching. (2025/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The Emergence of Drug Resistance in Extrapulmonary Tuberculosis: A Case Series. (2025/10/01) ♡
- Prevalence and factors influencing drug-resistant tuberculosis in four regions of Ghana. (2025/09/09) ♡
- The potential impact, cost and cost-effectiveness of tuberculosis interventions - a modelling exercise. (2025/09/04) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial. (2025/09/01) ♡
- Comparing the longer regimen and the shorter regimen for multidrug-resistant pulmonary tuberculosis patients treated under the programmatic management of drug-resistant tuberculosis. (2025/08/28) ♡
- Integrating Traditional Medicine with Conventional Therapies to Combat Tuberculosis: A Comprehensive Review. (2025/08/15) ♡
- Chest x-ray features and their associated factors among rifampicin/multi-drug-resistant tuberculosis patients in drug-resistant tuberculosis treatment initiating centers in Addis Ababa, Ethiopia: a retrospective study. (2025/08/02) ♡
- Factors Predictive of Early Discontinuation of Preventive Treatment in Children With Household Exposure to Multidrug-resistant Tuberculosis. (2025/07/18) ♡
- Tuberculosis Prevention, Control, and Elimination. (2025/07/06) ♡
- Clinical spectrum of tuberculosis in adolescents (10-19 years) in a tertiary care center of North India. (2025/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug resistant tuberculous meningitis: A neglected foe in ending tuberculosis epidemic. (2025/07/01) ♡
- High Rates of Mortality During Drug-Resistant Tuberculosis Treatment Among Individuals With Diabetes Mellitus and Low Body Mass Index. (2025/06/25) ♡
- The prevalence of undernutrition and associated risk factors in people with tuberculosis in Lao People's Democratic Republic. (2025/06/20) ♡
- Evaluation of Social and Clinical Factors Associated with Adverse Drug Reactions Among Children with Drug-Resistant Tuberculosis in Pakistan. (2025/06/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutritional Deficiencies and Management in Tuberculosis: Pharmacotherapeutic and Clinical Implications. (2025/05/30) ♡
- Impact of malnutrition and associated factors on rifampicin/multi-drug-resistant tuberculosis treatment outcomes among patients treated in alert and St. Peter's Specialized Hospitals, Addis Ababa, Ethiopia: a retrospective follow-up study. (2025/05/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A cationic main-chain poly(carbonate-imidazolium) potent against Mycobacterium abscessus and other resistant bacteria in mice. (2025/05/01) ♡
- Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis. (2025/05/01) ♡
- Sputum culture conversion and its predictors among drug-resistant pulmonary tuberculosis patients in eastern Ethiopia. (2025/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Does malnutrition play an essential role in developing drug-resistant tuberculosis, and how can it be prevented? (2025/05/01) ♡
- Prioritization of novel anti-infective stilbene derivatives by combining metabolomic data organization and a stringent 3R-infection model in a knowledge graph. (2025/04/23) ♡
- Drug-Resistant Tuberculosis in Western Province, Papua New Guinea: Is Health Securitisation the Answer, or Merely a PHEIC Promise? (2025/04/21) ♡
- Leveraging Artificial Intelligence to Predict Potential TB Hotspots at the Community Level in Bangui, Republic of Central Africa. (2025/04/03) ♡
- Comparison of HIV-1 RNA and HIV-1 DNA Genotypic Drug Resistance Testing in Women of Childbearing Age Infected with HIV-1 in Liangshan Prefecture. (2025/04/01) ♡
- Clinical Significance of Various Pathogens Identified in Patients Experiencing Acute Exacerbations of COPD: A Multi-center Study in South Korea. (2025/04/01) ♡
- Presumed Levofloxacin-associated Lichenoid Drug Eruption in a Child With Rifampicin-resistant Tuberculosis. (2025/04/01) ♡
- Loss to follow-up: Understand its determinants among tuberculosis patients, in Coimbra District (2005-2017). (2025/04/01) ♡
- Empowering care: Unleashing pharmaceutical care to confront MDR-TB transmission risks-A prospective interventional study. (2025/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Changing trends in duration of treatment of musculoskeletal and spinal tuberculosis- long term experience in a tertiary care teaching hospital. (2025/04/01) ♡
- CLINICALLY RELEVANT METALLIC NANOPARTICLES IN TUBERCULOSIS DIAGNOSIS AND THERAPY. (2025/04/01) ♡
- Inhalational Delivery of β-glucan-chitosan-poly(lactic co-glycolic) acid Nanoparticles Enhance Alveolar Macrophage Rifampin Concentrations for the Treatment of Tuberculosis. (2025/04/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of High-Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants. (2025/04/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Clinical practice guideline for the evaluation, treatment, and follow-up of children in contact with patients with pulmonary tuberculosis in Colombia. (2025/03/30) ♡
- Clinical Characteristics of Nontuberculous Mycobacterial Positivity Occurring During Multidrug-Resistant Tuberculosis Treatment: A Retrospective Study. (2025/03/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Global perspectives on tuberculosis in prisons and incarceration centers - Risk factors, priority needs, challenges for control and the way forward. (2025/03/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Addressing key risk factors hindering tuberculosis control activities in West Africa - progress in meeting the UN sustainable development goals. (2025/03/19) ♡
- Treatment outcomes of pulmonary TB in adults in Indonesia. (2025/03/12) ♡
- Patterns of Quetelet Index (Body Mass Index) Improvement and Associated Clinical Factors During Initial Tuberculosis Treatment: A Prospective Analysis of Newly Diagnosed Tuberculosis Patients. (2025/03/12) ♡
- Prevalence of extrapulmonary tuberculosis and factors influencing successful treatment outcomes among notified cases in South India. (2025/03/10) ♡
- Analogue of the natural product ecumicin causes sustained growth inhibition of Mycobacterium tuberculosis under multiple growth conditions. (2025/03/01) ♡
- Outcomes of Treating Tuberculosis Patients with Drug-Resistant Tuberculosis, Human Immunodeficiency Virus, and Nutritional Status: The Combined Impact of Triple Challenges in Rural Eastern Cape. (2025/02/20) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Pharmacokinetics of ethambutol and weight banded dosing in South African adults newly diagnosed with tuberculosis and HIV. (2025/02/13) ♡
- Systematic Screening for Tuberculosis Using Molecular Testing on Stool Samples in Acutely Malnourished Children: A Pilot Implementation Study in a High-Burden Drug-Resistant Tuberculosis Country. (2025/02/13) ♡
- [Chinese expert consensus on diagnosis and treatment of non-tuberculous mycobacterial pulmonary disease complicated with bronchiectasis]. (2025/02/12) ♡
- Characteristics and treatment outcomes of adolescents and young adults living with HIV with drug-resistant tuberculosis co-infection in Uganda: a retrospective cohort study. (2025/02/12) ♡
- Efficacy of carbonyl cyanide-3-chlorophenylhydrazone in combination with antibiotics against Mycobacterium abscessus. (2025/02/04) ♡
- Dynamics, mechanistic and energetic evaluation of thiazole-thiadiazole compounds in flavin dependent thymidylate synthase of Mycobacterium tuberculosis. (2025/02/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.